Uncategorized
Featured Stories
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. to Participate in the Bank of America Securities 2022 Healthcare Conference
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Bank of America Securities 2022 Healthcare…
-
DaVita Inc. 1st Quarter 2022 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2022. For the quarter, diluted earnings per share was $1.61, a decrease of (10.1)% from the prior…
-
DaVita Celebrates 2021 ESG, Corporate Social Responsibility Achievements
Today, DaVita Inc. highlighted its continued commitment to corporate citizenship with the publication of its annual Community Care Environmental Social Governance (ESG) Report. “I’m humbled…
-
DaVita Inc. Schedules 1st Quarter 2022 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time. The company plans to…
-
DaVita Announces Jason M. Hollar to Join its Board of Directors
DaVita Inc. announced today that its board of directors appointed a new independent director, Jason M. Hollar, to join the board, effective May 6, 2022. Mr. Hollar brings more than 25 years of…